Genzyme Corporation And National Organization for Rare Disorders Establish Program To Help Undiagnosed Patients With Rare Diseases
Published: Dec 16, 2013
CAMBRIDGE, Mass. & DANBURY, Conn.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), and the National Organization for Rare Disorders (NORD) today announced the creation of a fund to pay for standard diagnostic testing for people with mysterious, undiagnosed medical conditions. The fund will help those who have applied to the National Institutes of Health (NIH) Undiagnosed Diseases Program, but who cannot afford the basic medical tests needed to make them eligible to participate in the NIH program.
Help employers find you! Check out all the jobs and post your resume.